Temporomandibular disorders of masticatory muscle pain
Conditions
Interventions
Subjects will be divided into two groups with different frequency of use of the test product.
Group A will use a placebo at the start and an Active at the visit after 2weeks and 3 weeks.
Group B will
Sponsors
Naito Yosuke
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Adult men and women under 65 2.Japanese 3.Patients diagnosed with temporomandibular disorders and masticatory muscle pain disorders 4.Persons who have fully understood their participation in this research and obtained written consent at their own free will.
Exclusion criteria
Exclusion criteria: 1. Subjects with diseases or disorders that require differentiation from temporomandibular disorders 2. Subjects who were taking anti-inflammatory analgesics, central muscle relaxants, antidepressants, or sleep-inducing drugs within 1 month from the time of the first visit 3. Subjects who received local treatment such as intramuscular injection into the muscles of mastication within 3 months from the first visit 4. Subjects who received occlusal therapy (sprint therapy, occlusal adjustment method), electrical stimulation therapy for the muscles of mastication, hyperthermia, massage, and other physical therapies within 3 months of the initial visit. 5. Subjects who have undergone surgical therapy (temporomandibular joint pumping therapy, temporomandibular joint endoscopic surgery, temporomandibular joint open surgery, cusp tendonectomy for masticatory muscle tendon / tendon membrane hyperplasia, etc.) 6. Subjects with complications such as musculoskeletal disorders that interfere with the performance of the test when participating in or conducting clinical research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Doctor's diagnosis (temporomandibular joint noise, palpation, opening amount) | — |
Contacts
Public ContactTakeshi Kaneko
Japan Clinical Trial Association
Outcome results
None listed